Nabriva Therapeutics Ag Stock Predictions

Healthcare > Biotechnology

Buy NBRV

*Your capital is at risk

$1.42

+0 (+0%)

At Close: Nov 24, 2023

Currently predicting for Fri, 5 Jun 2026

NBRV Prediction Chart

NBRV Predictions History

Latest community submissions for NBRV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Mar 12, 2019	$2.40 -90.12%	$2.43	V	98.80%	1
Sergiu @Sergiu.103823	Mar 12, 2019	$2.48 -89.79%	$2.43	V	97.90%	0
marti @marti.80451	Jun 22, 2018	$3.68 -3.66%	$3.82	X	96.30%	0
marti @marti.80451	Jun 19, 2018	$5.80 +35.51%	$4.28	X	64.49%	0
JS Pro	May 22, 2018	$4.62 +1.54%	$4.55	X	98.50%	0
marti @marti.80451	May 22, 2018	$4.28 -5.93%	$4.55	X	94.10%	0
JS Pro	Nov 15, 2017	$5.54 +0.00%	$5.54	X	100.00%	10

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NBRV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT NABRIVA THERAPEUTICS AG

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also dev...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by